|
The new Pearls of TACEModerators: Prof. P. Pereira and Dr. G. Verset Agenda
Evolving role of TACE in HCC
BioPearl™: The first resorbable drug eluting microspheres
Advantages of feeding artery reperfusion
The BIOPEARL-ONE study
Panel discussion
|
|
Panel of experts |
Prof. Philippe Pereira SLK-Kliniken GmbH Heilbronn, Germany |
|
|
|
Dr. Gontran Verset Institut Paoli-Calmettes Marseille, France |
|
|
|
Prof. Irene Bargellini Candiolo Cancer Institute IRCCS Turin, Italy |
|
|
|
Ty Naccarato Microvention Research and Development Aliso Viejo, USA |
|
|
|
Dr. Tommaso Cascella Istituto Nazionale Tumori Milan, Italy |
|
|
|
Prof. Roberto Iezzi Policlinico Universitario Agostino Gemelli Rome, Italy |
|
|
|
|
|
|
Further information about our session duringECIO 2024 |
|
|
|
|